| |
99,49%
| Gesundheit |
| |
7,67%
| Eli Lilly and Company Ltd |
| |
5,31%
| Novartis AG |
| |
4,82%
| AstraZeneca plc |
| |
4,48%
| AbbVie Inc |
| |
4,28%
| Johnson & Johnson Corp |
| |
3,21%
| UnitedHealth Group Inc |
| |
3,10%
| NOVO NORDISK CLASS B |
| |
2,90%
| Gilead Sciences Inc |
| |
2,40%
| Vertex Pharmaceuticals Inc |
| |
2,40%
| Cencora Inc |
| |
68,32%
| USA |
| |
10,57%
| Schweiz |
| |
5,34%
| Großbritannien |
| |
5,02%
| Dänemark |
| |
4,98%
| Japan |
| |
1,43%
| Deutschland |
| |
1,22%
| Australien |
| |
1,20%
| Belgien |
| |
1,02%
| Frankreich |